Chinese contract firms are expected to take various measures to cope with the expected long-term impacts of the BIOSECURE Act that became law in the US in December 2025. (Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
